Next |
home / stock / gnftf / gnftf message board
Subject | By | Source | When |
---|---|---|---|
GNFT - Friday Rundown, Monday Expectations | Jake L | investorshub | 12/18/2021 5:40:03 AM |
GNFT formally axes NASH drugwill continue work on | DewDiligence | investorshub | 07/22/2020 8:52:53 PM |
Genfit claims advance in non-invasive NASH diagnostic: #msg-132439027. | DewDiligence | investorshub | 06/23/2017 3:23:36 PM |
Phase-3 NASH trial has slower-than-expected enrollment: #msg-130748127. | DewDiligence | investorshub | 04/24/2017 3:32:42 PM |
Big event happening March 9th!!! | Orangefan1974 | investorshub | 03/03/2017 12:25:00 AM |
yea good pop tho | gregque | investorshub | 03/02/2017 3:43:38 PM |
At this point, it's merely a rumornot real news. | DewDiligence | investorshub | 03/02/2017 3:37:42 PM |
thnx DD great news wow | gregque | investorshub | 03/02/2017 3:31:23 PM |
GNFT.PA +29% on SA piece re $NVS buyout rumor: | DewDiligence | investorshub | 03/02/2017 3:29:00 PM |
ive heard nothing yet | gregque | investorshub | 03/02/2017 12:19:52 PM |
Any news? | RTR-1 | investorshub | 03/02/2017 2:54:41 AM |
HAPPY NEW YEAR | gregque | investorshub | 01/05/2017 12:22:38 AM |
buying all i can | gregque | investorshub | 01/04/2017 9:19:28 PM |
im long GNFTF the uplisting to nasdaq is | gregque | investorshub | 12/30/2016 4:55:49 PM |
GENFIT ANNOUNCES POSITIVE RESULTS FROM | Wildbilly | investorshub | 09/16/2015 2:40:08 AM |
Dump Intercept And Buy Genfit | Wildbilly | investorshub | 06/19/2015 4:48:11 PM |
Genfit: Why Intercept's NASH Phase 3 Design Is | Wildbilly | investorshub | 05/20/2015 1:46:13 PM |
LOL $73.10 x 48.29 they really need to | Wildbilly | investorshub | 04/21/2015 7:54:02 PM |
$GNFTF recent news/filings | stocktrademan | investorshub | 04/16/2015 3:55:35 PM |
Genfit: Refuting Bearish Arguments About Genfit's Results - | Wildbilly | investorshub | 04/07/2015 12:58:01 AM |
News, Short Squeeze, Breakout and More Instantly...
Genfit Ord Company Name:
GNFTF Stock Symbol:
OTCMKTS Market:
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 14, 2024 - GENFIT (Nasdaq and Euronext: GNFT) , a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced its cash pos...
Lille (France), Cambridge (Massachusetts, USA), Zurich (Switzerland), April 25, 2024 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company committed to improving the lives of patients with rare, life-threatening liver diseases, today announced the publication of its 2...
Lille (France); Cambridge (Massachusetts, United States); Zurich (Switzerland); April 15, 2024 - GENFIT (Nasdaq and Euronext: GNFT) , a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced that it pu...